HIGHLIGHTS
- who: Tristan Struja from the Division of, Diabetes and Metabolism, Medical University Department, Kantonsspital Aarau, Aarau, Medical Faculty, University of Basel, Basel, Switzerland have published the paper: Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study, in the Journal: (JOURNAL)
- what: Metabolomic markers in our pilot study had only low to moderate prognostic potential for prediction of relapse of GD, with pyruvate and triglycerides being the most promising candidates with acceptable discriminatory ability.
- how: This study is the first to assess whether metabolomic differences can be used to predict relapse of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.